This trial will test whether CBD is an effective treatment for Rheumatoid Arthritis when taken alongside existing medication.
- Rheumatoid Arthritis
2 Primary · 2 Secondary · Reporting Duration: 12 weeks
Awards & Highlights
3 Treatment Groups
200mg CBD twice daily
1 of 3
400 mg CBD twice daily
1 of 3
1 of 3
60 Total Participants · 3 Treatment Groups
Primary Treatment: 200mg Cannabidiol by capsules twice daily · Has Placebo Group · Phase 1 & 2
Who is running the clinical trial?
Age 18+ · All Participants · 1 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Is enrollment currently open for this experiment?
"According to the information shared on clinicaltrials.gov this research project is actively enrolling participants. It was originally posted online on October 5th 2021 and its details have been updated most recently on November 4th 2022." - Anonymous Online Contributor
What is the magnitude of participants that have been selected for this clinical trial?
"Affirmative. The clinicaltrial.gov database states that the trial, which was launched on October 5th 2021, is actively searching for volunteers. In total, 60 individuals are needed at 1 testing centre." - Anonymous Online Contributor
Are there any other studies that have looked into the effects of bimodal 200mg Cannabidiol supplementation?
"Currently, 79 trials are underway to examine the efficacy of a 200mg Cannabidiol capsule dosage administered twice daily. Of these studies, 16 are in their final stages (Phase 3) and taking place mainly in Ribeirao Preto and Sao Paulo. Across 290 different sites worldwide, various experiments involving this treatment are being conducted." - Anonymous Online Contributor